iHuman Inc.IHNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank64
5Y CAGR-35.6%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-35.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 4.11% |
| Q2 2025 | -4.61% |
| Q1 2025 | -12.52% |
| Q4 2024 | 6.75% |
| Q3 2024 | 3.65% |
| Q2 2024 | -15.76% |
| Q1 2024 | 2.46% |
| Q4 2023 | 0.19% |
| Q3 2023 | 4.35% |
| Q2 2023 | 2.82% |
| Q1 2023 | -7.67% |
| Q4 2022 | -7.05% |
| Q3 2022 | -8.11% |
| Q2 2022 | -19.07% |
| Q1 2022 | -11.42% |
| Q4 2021 | -16.79% |
| Q3 2021 | 40.87% |
| Q2 2021 | 13.32% |
| Q1 2021 | 17.35% |
| Q4 2020 | 25.25% |
| Q3 2020 | 37.20% |
| Q2 2020 | 23.55% |
| Q1 2020 | 7.58% |
| Q4 2019 | 16.25% |
| Q3 2019 | -53.43% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |